PFIZER, INC. | Pfizer | Missouri | state | 2000 | $315,055 | | tax credit/rebate |
Sanofi US Services, Inc. | Sanofi | Pennsylvania | state | 2014 | $314,989 | | tax credit/rebate |
Shire ViroPharma Incorporated | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $312,596 | | tax credit/rebate |
Dr. Reddy's Laboratories Tennessee, LLC | Dr. Reddy's Laboratories | Tennessee | state | 2013 | $312,500 | | training reimbursement |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | Florida | state | 2000 | $312,000 | | tax credit/rebate |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2009 | $310,000 | | training reimbursement |
OMEROS CORPORATION | Omeros Corp. | Washington | state | 2016 | $309,936 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2017 | $305,389 | | tax credit/rebate |
Biogen Idec US Limited Partnership | Biogen | North Carolina | state | 2008 | $305,070 | | tax credit/rebate |
Eli Lilly & Company | Eli Lilly | Pennsylvania | state | 2021 | $303,000 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2016 | $302,614 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $302,558 | | tax credit/rebate |
Cambrex Charles City, Inc. | Cambrex | Iowa | State | 2017 | $300,898 | | grant/loan hybrid program |
Foundation Medicine, Inc. | Roche | Massachusetts | state | 2013 | $300,309 | | tax credit/rebate |
Cambridge Major Laboratories, Inc. | Alcami | Wisconsin | state | 2011 | $300,000 | | tax credit/rebate |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $300,000 | | grant |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2012 | $300,000 | | training reimbursement |
Moderna Therapeutics | Moderna Inc. | Massachusetts | state | 2014 | $300,000 | | tax credit/rebate |
SUCAMPO PHARMACEUTICALS INC | Mallinckrodt | Maryland | local | 2016 | $300,000 | | grant/loan hybrid program |
Abbott Laboratories | Abbott Laboratories | Virginia | state | 2016 | $300,000 | | grant |
Johnson & Johnson Health Care Systems Inc. | Johnson & Johnson | Indiana | state | 2010 | $300,000 | | tax credit/rebate |
Bausch & Lomb | Bausch Health | Virginia | state | 2023 | $300,000 | | grant |
Abbott Laboratories | Abbott Laboratories | Virginia | state | 2020 | $300,000 | | grant |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2012 | $299,453 | | tax credit/rebate; property tax abatement |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $298,738 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2013 | $298,709 | | tax credit/rebate |
Immunex Corporation | Amgen | Pennsylvania | state | 2012 | $297,513 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2012 | $296,213 | | tax credit/rebate |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2004 | $294,900 | | tax credit/rebate |
Shire Human Genetic Therapies Inc | Takeda Pharmaceutical | Pennsylvania | state | 2021 | $294,400 | | tax credit/rebate |
ICOS CORPORATION | Eli Lilly | Washington | state | 2006 | $293,138 | | tax credit/rebate |
SAFC, Inc. | Merck KGaA (EMD) | Wisconsin | state | 2008 | $292,500 | | tax credit/rebate |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2008 | $290,648 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2008 | $290,648 | | enterprise zone |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | New Jersey | state | 2010 | $289,800 | | tax credit/rebate |
Novo Nordisk Pharmaceutical Industr | Novo Holdings A/S | North Carolina | state | 2012 | $288,000 | | grant |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2017 | $285,887 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2016 | $284,933 | | tax credit/rebate |
ImClone Systems | Eli Lilly | New Jersey | state | 2010 | $283,500 | | Tax credit/rebate |
Regeneron Pharmaceuticals II | Regeneron Pharmaceuticals | New York | local | 2019 | $283,003 | | tax credit/rebate |
ETHICON ENDO-SURGERY INC | Johnson & Johnson | New Mexico | state | 2012 | $281,091 | | tax credit/rebate |
WYETH HOLDINGS CORPORATION | Pfizer | New York | local | 2009 | $280,900 | | tax credit/rebate; property tax abatement |
Hospira, Inc. | Pfizer | North Carolina | state | 2019 | $280,119 | | tax credit/rebate |
Regeneron - 1 CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2017 | $279,865 | | tax credit/rebate |
Abraxis BioScience, Inc. | Bristol-Myers Squibb | Arizona | state | 2009 | $279,390 | | training reimbursement |
Hospira, Inc. | Pfizer | North Carolina | state | 2016 | $277,903 | | tax credit/rebate |
Genzyme Corporation | Sanofi | New Mexico | state | 2008 | $277,372 | | training reimbursement |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2011 | $277,248 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2017 | $275,871 | | tax credit/rebate |
Idexx Distribution Inc | IDEXX Laboratories | Maine | state | 2021 | $275,737 | | tax credit/rebate |
Albany Molecular | Curia Inc. | New York | local | 2007 | $275,469 | | tax credit/rebate; property tax abatement |
Bristol-Myers Squibb Company, Inc. | Bristol-Myers Squibb | New York | state | 2002 | $275,000 | | enterprise zone |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2016 | $274,743 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2016 | $274,029 | | tax credit/rebate |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2014 | $273,219 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2016 | $273,143 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2014 | $273,088 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2013 | $272,967 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2015 | $271,549 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2010 | $270,783 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2016 | $269,391 | | tax credit/rebate |
Bausch & Lomb | Bausch Health | New York | local | 2003 | $266,156 | | tax credit/rebate; property tax abatement |
Albany Molecular | Curia Inc. | New York | local | 2006 | $266,119 | | tax credit/rebate; property tax abatement |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $265,000 | | training reimbursement |
Steel Forest, LLC | AbbVie | New York | local | 2022 | $264,555 | | tax credit/rebate |
I C O S CORP | Eli Lilly | Washington | state | 2004 | $263,847 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | Local | 2018 | $262,770 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2013 | $261,281 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2021 | $261,116 | | tax credit/rebate |
IDEXX Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2008 | $260,807 | | tax credit/rebate |
Albany Molecular | Curia Inc. | New York | local | 2005 | $258,802 | | tax credit/rebate; property tax abatement |
Immunex Rhode Island Corp. | Amgen | Rhode Island | state | 2013 | $258,315 | | tax credit/rebate |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2003 | $257,000 | | enterprise zone |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2013 | $255,775 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2016 | $254,454 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2018 | $254,453 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $254,292 | | tax credit/rebate |
Albany Molecular | Curia Inc. | New York | local | 2012 | $253,726 | | tax credit/rebate; property tax abatement |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2014 | $253,035 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2004 | $253,000 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2011 | $252,000 | | tax credit/rebate |
Lupin, Inc. | Lupin Limited | Florida | state | 2014 | $252,000 | | tax credit/rebate |
IDEXX Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2009 | $251,851 | | tax credit/rebate |
MacroGenics, Inc. and Subsidiaries | MacroGenics | Maryland | state | 2008 | $251,056 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2013 | $250,478 | | tax credit/rebate |
BioRexis | Pfizer | Pennsylvania | state | | $250,000 | | training reimbursement |
PHARMAFORCE INC | Daiichi Sankyo | Ohio | state | 2009 | $250,000 | | grant |
Astrazeneca Pharmaceuticals, Lp | AstraZeneca | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Gilead Sciences, Inc. & Subsidiaries | Gilead Sciences | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Macrogenics, Inc. | MacroGenics | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Novavax, Inc. | Novavax Inc. | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Emergent Biosolutions | Emergent BioSolutions | Maryland | local | 2014 | $250,000 | | infrastructure assistance |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2012 | $249,570 | | training reimbursement |
BOEHRINGER INGELHEIM FREMONT INC | Boehringer Ingelheim | California | state | 2017 | $249,388 | | training reimbursement |
BOEHRINGER INGELHEIM FREMONT, INC. | Boehringer Ingelheim | California | state | 2014 | $248,794 | | training reimbursement |
Albany Molecular | Curia Inc. | New York | local | 2009 | $248,601 | | tax credit/rebate; property tax abatement |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2009 | $246,912 | | tax credit/rebate |
Abbott Point of Care | Abbott Laboratories | New Jersey | state | 2009 | $246,400 | | tax credit/rebate |
Daiichi Sankyo, Inc. | Daiichi Sankyo | Pennsylvania | state | | $246,000 | | tax credit/rebate |
Regeneron Renovation/Equipment | Regeneron Pharmaceuticals | New York | local | 2016 | $245,303 | | tax credit/rebate |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2008 | $244,623 | | tax credit/rebate; property tax abatement |